Indiana Stop-Sale System Shows Effectiveness of Real-Time, Blocking Technology in the Fight Against Illegal Sales of Pseudoephedrine
LUTHERVILLE, Md., Dec. 14, 2011 /PRNewswire/ — The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today applauded data showing the National Precursor Log Exchange (NPLEx) in Indiana is blocking illegal sales of medications containing pseudoephedrine (PSE). In just five months and with deployment of the system 75 percent complete, the real-time, stop-sale technology has blocked the sale of more than 17,000 boxes of PSE-containing medicines in the Hoosier State. Furthermore, in November alone, the system proved to be a helpful tool for law enforcement with more than 5,000 data searches performed by Indiana law enforcement. All of this activity was achieved before the mandatory January 1, 2012 implementation date.
“The data released by the National Precursor Log Exchange (NPLEx) shows recently passed legislation in Indiana putting in place a real-time, stop-sale system is already having a positive impact in the battle against methamphetamine,” said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). “In less than six months, NPLEx has blocked the sale of more than 17,000 boxes of products containing pseudoephedrine from being sold illegally in Indiana for a total of more than 38,000 grams potentially being kept off the street. And while there is still some work to do to complete Indiana’s deployment in every pharmacy and retail store selling products containing pseudoephedrine, electronic technology is proving it works in Indiana and blocks illegal sales, while ensuring law-abiding citizens with colds and allergies can access the popular and reliable medicines they need.”
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE The National Association of Drug Diversion Investigators